Institut Pasteur, Paris

  • Emerging Diseases Epidemiology Unit. Institut Pasteur, Paris

The Emerging Diseases Epidemiology Unit has been created in 2001 and has collaborative projects with developing countries on viral emerging diseases (HIV, HCV, SARS, dengue). The group is composed by five senior researchers, one biostatistician, one doctoral student, three MPH students, one public health resident, one data manager, and one secretary.

 

Staff

Prof. Arnaud Fontanet leads this group. He was trained as a medical doctor in France, and got his PhD in the epidemiology of infectious diseases at the Harvard School of Public Health. He has since worked in the field of infectious and tropical diseases in Asia and Africa, and has followed several cohort studies on HIV and HCV. From 1994 to 1999, he has been the expatriate Project Manager of the Ethio-Netherlands AIDS Research Project, a multidisciplinary research project on AIDS in Addis Ababa, Ethiopia. Since 2000, he is the P.I. and scientific coordinator of international and multidisciplinary research projects on HCV in Egypt and SARS in China.

The multi-disciplinarity of the team allows a comprehensive approach of viral hepatitis research in Egypt: Arnaud Fontanet (analytical epidemiology), Muriel Vray (clinical research), Michel Garenne (demography), Tamara Giles-Vernick (medical anthropology), Romulus Breban (mathematical modeling), Aline Munier (analytical epidemiology), Adeline Bernier (epidemiology and public health), Lénaig Le Fouler (data management and biostatistics), and Loic Chartier (data management and biostatistics).

 

Role in the collaboration

Prof. Arnaud Fontanet is the "North" coordinator for the ANRS Egypt site. Expertise in epidemiology, clinical research and biostatistics.

 

  • Laboratory of Dendritic Cell Immunobiology. Institut Pasteur, Paris & INSERM U818

The Laboratory of Dendritic Cell Immunobiology was created in 2003 and is focused on defining the role of dendritic cells in the pathogenesis of viral infection and cancer. In particular, the lab concentrates on HCV infection and bladder cancer. The group is composed by six scientists (three students, two post-docs and one medical fellow), one engineer, one technician and one clinical coordinator / projects manager. In addition, we co-sponsor one student (Hala Mansour) who works principally in Cairo on the ANRS sponsored study concerning the role of DCs in HCV pathogenesis.

 

Staff

Dr. Matthew Albert leads this group. He was trained as a medical doctor in the USA, and received his PhD in immunology at The Rockefeller University. He has since worked in the fields of tumor immunity and infectious disease and has led several clinical studies including one interventional trial and four observational studies. Since 2003, he has been the P.I. of the Laboratory of Dendritic Cell Immunobiology, focused on defining the role of dendritic cells in the pathogenesis of viral infection and cancer. In particular, the lab concentrates on HCV infection and bladder cancer. The group is composed by six scientists (three students, two post-docs and one medical fellow), one engineer, one technician and one clinical coordinator / projects manager.

Team members: Matthew Albert, Darragh Duffy, Armanda Casrouge, Stéphanie Thomas.

 

Role in the collaboration
Coordination of the immunology studies, study of immune correlates of HCV disease pathogenesis.

 

Back to team members

NEWS & EVENT

Introduction of Sofosbuvir in Egypt

In July 2014, Gilead and the Egyptian government signed an agreement for a treatment expansion of Sovaldi® (Sofosbuvir). Read more

Scientific Advisory Board Meeting

The Scientific Advisory Board Meeting was held in Paris February 15-16, 2013.

Read more



fp7_01fp7_02 This project is funded
by the European Union